This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Oxaloacetate Supplementation for Emotional PMS

Sponsored by Terra Biological LLC

About this trial

Last updated 7 years ago

Study ID

EmotionalPMS1

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 50 Years
Female
Female

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 8 years ago

What is this trial about?

Emotional Premenstrual Syndrome (PMS) affects millions of women worldwide. For Emotional PMS, including depression, anxiety, perceived stress and aggression, there are very few options. Recent observational data suggest that nutritional supplementation with oxaloacetate, a human energy metabolite, greatly reduced the symptoms of Emotional PMS. The aim of this study was to confirm these observations on the effects of oxaloacetate on Emotional PMS symptom severity within a controlled clinical trial setting.

What are the participation requirements?

Yes

Inclusion Criteria

- Women with Emotional Premenstrual Syndrome (PMS),

- Women who speak English as their primary language

- Women who understand the Human Consent Form

- Ability to swallow capsules

No

Exclusion Criteria

- Formal diagnosis of clinical depression

- Formal diagnosis of premenstrual dysphoric disorder (PMDD).